Free Trial
LON:BXP

Beximco Pharmaceuticals (BXP) Share Price, News & Analysis

Beximco Pharmaceuticals logo
GBX 34 +1.50 (+4.62%)
(As of 07:02 AM ET)

About Beximco Pharmaceuticals Stock (LON:BXP)

Key Stats

Today's Range
32.50
34
50-Day Range
21
35
52-Week Range
19.33
43.75
Volume
5,000 shs
Average Volume
158,500 shs
Market Capitalization
£151.68 million
P/E Ratio
425.00
Dividend Yield
8.82%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

Receive BXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

BXP Stock News Headlines

Beximco Pharma Share Chat (BXP)
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar
As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.
Beximco Pharma Share Chat
Beximco Pharmaceuticals Ltd DR
See More Headlines

BXP Stock Analysis - Frequently Asked Questions

Beximco Pharmaceuticals' stock was trading at GBX 41.50 at the start of the year. Since then, BXP stock has decreased by 18.1% and is now trading at GBX 34.
View the best growth stocks for 2024 here
.

Shares of BXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Beximco Pharmaceuticals investors own include Advanced Micro Devices (AMD), Bank of America (BAC), Exxon Mobil (XOM), Salesforce (CRM), Chevron (CVX), Meta Platforms (META) and NIKE (NKE).

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Trading
CIK
N/A
Fax
N/A
Employees
5,500
Year Founded
N/A

Profitability

Net Income
£5.33 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£43.08 billion
Book Value
£104.17 per share

Miscellaneous

Free Float
N/A
Market Cap
£151.68 million
Optionable
Not Optionable
Beta
0.61
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (LON:BXP) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners